Discovery of pyrimidine benzimidazoles as Lck inhibitors: Part I
Authors:
- 15 October 2008
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 18 (20) , 5618-5621
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Discovery of 2-amino-6-carboxamidobenzothiazoles as potent Lck inhibitorsBioorganic & Medicinal Chemistry Letters, 2008
- Entry into a new class of protein kinase inhibitors by pseudo ring designBioorganic & Medicinal Chemistry Letters, 2008
- Verification of a Designed Intramolecular Hydrogen Bond in a Drug Scaffold by Nuclear Magnetic Resonance SpectroscopyJournal of Medicinal Chemistry, 2007
- An efficient rapid system for profiling the cellular activities of molecular librariesProceedings of the National Academy of Sciences, 2006
- Discovery of A-770041, a src-family selective orally active lck inhibitor that prevents organ allograft rejectionBioorganic & Medicinal Chemistry Letters, 2006
- Inhibitors of p56lck: assessing their potential as tools for manipulating T-lymphocyte activationExpert Opinion on Therapeutic Patents, 2001
- LANCE™: Homogeneous Assay Platform for HTSSLAS Discovery, 1999
- Structural basis for activation of human lymphocyte kinase Lck upon tyrosine phosphorylationNature, 1996
- Lck regulates the tyrosine phosphorylation of the T cell receptor subunits and ZAP-70 in murine thymocytes.Journal of Experimental Medicine, 1996
- Genetic evidence for the involvement of the lck tyrosine kinase in signal transduction through the T cell antigen receptorCell, 1992